| 0 | ℹ |
Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.
(nature.com)
|
Nature Medicine 2026-03-01 | #immunotherapy #melanoma #biomarker #neoadjuvant #checkpoint inhibitor | |
| 0 | ℹ |
Ancestry and somatic profile indicate acral melanoma origin and prognosis.
(nature.com)
|
Nature 2026-03-01 | #transcriptomics #cancer #melanoma #ancestry #mutation |